Pro Share Advisors LLC Bio N Tech Se Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Pro Share Advisors LLC holds 5,793 shares of BNTX stock, worth $716,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,793

Previous 6,053 4.3%

Holding current value

$716,999

Previous $486,000 41.56%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.36 - $124.66 $20,373 - $32,411	-260 Reduced 4.3%	5,793 $688,000
Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $58,823 - $75,300	-732 Reduced 10.79%	6,053 $486,000
Q1 2024 May 08, 2024	BUY	$88.96 - $112.35 $56,667 - $71,566	637 Added 10.36%	6,785 $625,000
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $3,636 - $4,510	40 Added 0.65%	6,148 $648,000
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $5,614 - $7,129	57 Added 0.94%	6,108 $663,000
Q2 2023 Aug 10, 2023	SELL	$102.58 - $129.66 $44,314 - $56,013	-432 Reduced 6.66%	6,051 $653,000
Q1 2023 May 11, 2023	SELL	$122.57 - $153.67 $137,646 - $172,571	-1,123 Reduced 14.76%	6,483 $807,000
Q4 2022 Feb 02, 2023	BUY	$118.43 - $186.05 $22,856 - $35,907	193 Added 2.6%	7,606 $1.14 Million
Q3 2022 Nov 04, 2022	BUY	$127.65 - $183.11 $70,207 - $100,710	550 Added 8.01%	7,413 $1 Million
Q2 2022 Aug 01, 2022	SELL	$123.25 - $186.24 $278,175 - $420,343	-2,257 Reduced 24.75%	6,863 $1.02 Million
Q1 2022 May 10, 2022	SELL	$126.25 - $231.85 $415,110 - $762,322	-3,288 Reduced 26.5%	9,120 $1.56 Million
Q4 2021 Feb 08, 2022	SELL	$216.64 - $362.52 $1.12 Million - $1.87 Million	-5,150 Reduced 29.33%	12,408 $3.2 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $681,422 - $1.48 Million	3,309 Added 23.22%	17,558 $4.79 Million
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $437,301 - $931,909	3,859 Added 37.14%	14,249 $3.19 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $12,945 - $18,044	151 Added 1.47%	10,390 $1.13 Million
Q4 2020 Feb 09, 2021	BUY	$72.71 - $129.54 $744,477 - $1.33 Million	10,239 New	10,239 $835,000

Others Institutions Holding BNTX

# of Institutions

360

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Bio N Tech Se Transaction History